Victory Capital Management’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$109K Buy
30,032
+4,768
+19% +$17.4K ﹤0.01% 2318
2025
Q1
$48.5K Sell
25,264
-417
-2% -$801 ﹤0.01% 2367
2024
Q4
$48.8K Buy
25,681
+336
+1% +$638 ﹤0.01% 2399
2024
Q3
$33.5K Buy
25,345
+518
+2% +$684 ﹤0.01% 2419
2024
Q2
$25.3K Buy
24,827
+3,010
+14% +$3.07K ﹤0.01% 2412
2024
Q1
$39.9K Sell
21,817
-702
-3% -$1.29K ﹤0.01% 2393
2023
Q4
$27.9K Sell
22,519
-732,969
-97% -$909K ﹤0.01% 2485
2023
Q3
$861K Buy
755,488
+93,590
+14% +$107K ﹤0.01% 1732
2023
Q2
$606K Buy
661,898
+404,154
+157% +$370K ﹤0.01% 1902
2023
Q1
$144K Buy
257,744
+237,922
+1,200% +$133K ﹤0.01% 2306
2022
Q4
$11.4K Sell
19,822
-8
-0% -$5 ﹤0.01% 2539
2022
Q3
$6K Sell
19,830
-4,148
-17% -$1.26K ﹤0.01% 2675
2022
Q2
$8K Buy
23,978
+965
+4% +$322 ﹤0.01% 2663
2022
Q1
$10K Sell
23,013
-657
-3% -$285 ﹤0.01% 2679
2021
Q4
$53K Sell
23,670
-677
-3% -$1.52K ﹤0.01% 2636
2021
Q3
$70K Buy
24,347
+883
+4% +$2.54K ﹤0.01% 2658
2021
Q2
$89K Buy
23,464
+276
+1% +$1.05K ﹤0.01% 2611
2021
Q1
$78K Buy
23,188
+669
+3% +$2.25K ﹤0.01% 2627
2020
Q4
$63K Buy
22,519
+1,330
+6% +$3.72K ﹤0.01% 2446
2020
Q3
$53K Sell
21,189
-1,138
-5% -$2.85K ﹤0.01% 2385
2020
Q2
$303K Sell
22,327
-15,585
-41% -$212K ﹤0.01% 2171
2020
Q1
$288K Buy
37,912
+7,801
+26% +$59.3K ﹤0.01% 2243
2019
Q4
$190K Buy
30,111
+10,163
+51% +$64.1K ﹤0.01% 2322
2019
Q3
$78K Buy
+19,948
New +$78K ﹤0.01% 2518